EUVIMEDEUVIMED entdecken
Crossref

Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors

Barbara Kreppel, Jana Fink, Christine Sanders, Anna Scherping, Oliver Hommerding, Milka Marinova, Ingo G H Schmidt-Wolf, Georg Feldmann, Maria Angeles Gonzalez-Carmona, Azin Jafari, Markus Essler, Glen Kristiansen

Nuklearmedizin - NuclearMedicine · 01.02.2026 · 65 (01) · 39-47

DOI: 10.1055/a-2739-5187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.02.2026. Verfasst von Barbara Kreppel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, T-Lymphocytes, Regulatory, Antigens, Differentiation, Myelomonocytic, Forkhead Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Medical Faculty of the University of Bonn, "Förderinstrument Klinische Studien" (FKS), Medical Faculty of the University of Bonn, “Förderinstrument Klinische Studien”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine tumors (NETs) are a heterogeneous group of malignancies characterized by variable immune microenvironment. This study aimed to analyze the infiltration of NETs by CD68+ tumor-associated macrophages (TAMs) and FoxP3+ regulatory T cells (Tregs) using Qupath software for semi-automated histopathological quantification Thirty-two patients with resected NETs were included. CD68 and FoxP3 expression were assessed by immunohistochemistry followed by automated cell detection and spatial analysis. The mean percentage of CD68+ cells was 0.35%, with no significant differences between pancreatic and gastrointestinal NETs. FoxP3+ cells were less frequent (mean: 0.06%), with higher levels in gastrointestinal NETs compared to pancreatic NETs (p < 0.05). Kaplan-Meier analysis revealed that CD68+ cells showed a trend to positive correlation with progression-free survival (PFS) and overall survival (OS). Thereby, patients exceeding a 0.1% CD68+ cell threshold exhibited longer survival (PFS: not reached vs. 106 months). In contrast, FoxP3+ cells showed a trend to inverse correlation with survival; patients with >0.05% FoxP3+ cells had shorter PFS (36 months vs. 147 months) and OS (180 months vs. not reached). Multivariate Cox regression identified N-stage as the sole predictor of OS. CD68+ TAM density was not associated with other clinical parameters, while FoxP3+ cell infiltration correlated significantly with venous invasion and advanced N- and M-stages. These findings highlight the potential prognostic relevance of immune cell infiltration in NETs and underscore the utility of Qupath for quantifying immune markers in histopathological analyses. The contrasting roles of CD68+ TAMs and FoxP3+ Tregs in the NET microenvironment warrant further exploration to inform immunotherapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsT-Lymphocytes, RegulatoryAntigens, Differentiation, MyelomonocyticForkhead Transcription FactorsMacrophagesAntigens, CDHumansMaleFemaleMiddle AgedPrognosisAgedAdultCD68 Molecule

Substanzen

Antigens, Differentiation, MyelomonocyticForkhead Transcription FactorsCD68 antigen, humanFOXP3 protein, humanAntigens, CDCD68 Molecule

Autor:innen und Institutionen

  • Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
  • Pathology, University Hospital Bonn, Bonn, Germany.
  • Department of Integrated Oncology, University Hospital Bonn, Bonn, Germany.
  • Department of Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
  • Department of Gastroenterology and Hepatology, University Hospital Bonn, Bonn, Germany.
  • Surgery, University Hospital Bonn, Bonn, Germany.

Förderung

  • Medical Faculty of the University of Bonn, "Förderinstrument Klinische Studien" (FKS)
  • Medical Faculty of the University of Bonn, “Förderinstrument Klinische Studien”

Zitieren

APA

Kreppel, B., Fink, J., Sanders, C., Scherping, A., Hommerding, O., Marinova, M., Schmidt-Wolf, I. G. H., Feldmann, G., Gonzalez-Carmona, M. A., Jafari, A., Essler, M., & Kristiansen, G. (2026). Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors. Nuklearmedizin - NuclearMedicine, 65(01), 39-47. https://doi.org/10.1055/a-2739-5187

Vancouver

Kreppel B, Fink J, Sanders C, Scherping A, Hommerding O, Marinova M, et al. Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors. Nuklearmedizin - NuclearMedicine. 2026;65(01):39-47. doi:10.1055/a-2739-5187

BibTeX
@article{Kreppel2026,
  author = {Kreppel, Barbara and Fink, Jana and Sanders, Christine and Scherping, Anna and Hommerding, Oliver and Marinova, Milka and Schmidt-Wolf, Ingo G H and Feldmann, Georg and Gonzalez-Carmona, Maria Angeles and Jafari, Azin and Essler, Markus and Kristiansen, Glen},
  title = {Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2026},
  volume = {65},
  number = {01},
  pages = {39--47},
  doi = {10.1055/a-2739-5187}
}
Kostenlos starten →